Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
22.65
+0.50 (2.26%)
Jun 27, 2025, 3:59 PM HKT

HKG:2315 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
9,0463,3954,78510,245--
Market Cap Growth
-29.05%-29.05%-53.29%---
Enterprise Value
9,2213,5624,68210,003--
Last Close Price
22.658.5011.9825.65--
PE Ratio
252.5695.11----
PS Ratio
8.673.256.0616.97--
PB Ratio
10.143.805.507.87--
P/TBV Ratio
10.453.925.738.12--
P/FCF Ratio
48.8218.32----
P/OCF Ratio
40.2415.10----
EV/Sales Ratio
8.843.415.9316.57--
EV/EBITDA Ratio
30.2611.58----
EV/EBIT Ratio
71.9622.29----
EV/FCF Ratio
49.7619.23----
Debt / Equity Ratio
0.680.680.690.360.070.06
Debt / EBITDA Ratio
1.801.80----
Debt / FCF Ratio
3.283.28----
Asset Turnover
0.400.400.270.210.15-
Inventory Turnover
26.8026.8012.256.096.11-
Quick Ratio
1.221.221.011.251.553.16
Current Ratio
1.531.531.251.521.963.49
Return on Equity (ROE)
4.12%4.12%-39.45%-50.12%-40.27%-
Return on Assets (ROA)
3.86%3.86%-6.94%-14.81%-14.02%-
Return on Capital (ROIC)
6.84%6.84%-12.56%-25.99%-22.52%-
Return on Capital Employed (ROCE)
8.00%8.00%----
Earnings Yield
0.39%1.05%-8.82%-6.64%--
FCF Yield
2.05%5.46%-4.68%-6.00%--
Buyback Yield / Dilution
0.08%0.08%-4.54%-5.13%-180.82%-
Updated Sep 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.